You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
POSTER: CASE STUDY<br />
Poster: Case Study<br />
P 402<br />
PYODERMA GANGRENOSUM – STILL CHALLENGING IN DIAGNOSIS AND<br />
TREATMENT<br />
Cornelia Erfurt-Berge 1 , Juergen Bauerschmitz 1<br />
1 University Hospital Erlangen, Department of Dermatology (Erlangen, Germany).<br />
Aim: Pyoderma gangraenosum is a painful, ulcerating skin disease of unknown<br />
aetiology. Diagnosis is generally based on clinical signs and histological examination is<br />
nonspecific. Associations with numerous systemic diseases have been described in the<br />
literature. Due to pathergy surgical measures can provoke an increase of the ulcers.<br />
Methods: A 79-year-old woman was referred to our department for evaluation of chronic<br />
leg ulcers which first appeared in 2007 on the right dorsal and the left lateral lower leg.<br />
Before first admission to our clinic, the patient was treated by her general practitioner<br />
under the diagnosis of venous leg ulcers. Several surgical interventions did not show<br />
any effort. Taken together the clinical findings with two deep ulcerated lesions with<br />
raised and undermined borders and a medical history of ulcers recalcitrant to<br />
phlebosurgical interventions and failure of skin grafts the diagnosis of pyoderma<br />
gangrenosum was taken into account and an immunosuppressive treatment was<br />
started. No underlying disease associated with pyoderma gangrenosum was detected.<br />
Results: After immunosuppressive medication with corticosteroids and dapsone was<br />
started the progress of the ulcerations stopped and after sufficient granulation tissue had<br />
developed by negative pressure therapy the wounds were provided successfully with<br />
split-thickness skin grafts.<br />
Conclusions: Although the clinical findings in cases of pyoderma gangrenosum may be<br />
very clear, the diagnosis remains complicated since histological findings are imprecise<br />
and many other diseases with similar appearance have to be excluded at first. Not<br />
before the inflammation is stopped by immunosuppressive medication more invasive<br />
strategies like surgical interventions should be performed.<br />
P 403<br />
EVALUATION OF A SILVER PRODUCT IN WOUND MANAGEMENT<br />
Poster: Case Study<br />
Jane Preece 1<br />
1 Whittington Hospital (London, United Kingdom).<br />
Aim: This poster aims to present two case studies evaluating the use of a Silver Alginate<br />
Dressing*.<br />
Method: Patient A: A 67 year old male presented with a lower leg ulcer to his left leg<br />
after it had been healed for 2 years. The wound measured 10cm x 12cm the wound bed<br />
was covered with healthy granulation tissue, but there was a large amount of exudate<br />
and clinical signs of infection.<br />
Patient B: A female with a 5 year history of bilateral venous disease presented with<br />
ulcers on both lower legs. It was decided to use the silver alginate dressing* only on the<br />
right leg for a two week period, to compare the treatment results between the legs.<br />
Results: Patient A: The ionic silver dressing* was used for a 2 week period, this resulted<br />
in a reduction in exudate now been to a minimal and no clinical signs of infection. After a<br />
3 week period the wound was completely healed, the patient was very pleased with the<br />
result.<br />
Patient B: Within a 2 week period the wound on the right leg had reduced in size by<br />
50%. The use of the silver alginate dressing* had kick started healing, a clear difference<br />
was observed between the right and the left leg. The wound on the left leg made no<br />
improvement and stayed the same.<br />
Conclusion: Silver has been commonly used as part of wound management for several<br />
years. Recently the use of silver has been questioned, since evaluating this specific<br />
silver product and introducing a protocol for use, the author has seen positive results in<br />
the progression and healing of wounds.<br />
*B.Braun Medical, Askina Calgitrol Ag<br />
<strong>EWMA</strong> <strong>2013</strong><br />
COPENHAGEN<br />
15-17 May · <strong>2013</strong><br />
Danish Wound<br />
Healing Society<br />
231